<ѻýҕl>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCCѻýҕl> "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
<ѻýҕl>Hold Off on Approving Anal Cancer Drug, Advisors Tell FDAѻýҕl> ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
<ѻýҕl>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻýҕl> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻýҕl>The FDA Is Failing the American Peopleѻýҕl> The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
<ѻýҕl>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care?ѻýҕl> News, features, and commentary about cancer-related issues Jun 10, 2021
<ѻýҕl>Bispecific Antibody Active in NRG1-Positive Pancreatic Cancerѻýҕl> Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
<ѻýҕl>Promising Early Data for Bladder-Sparing Cancer Treatmentѻýҕl> Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer Jun 09, 2021
<ѻýҕl>Perioperative Chemo Enough in Esophageal Cancer?ѻýҕl> MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
<ѻýҕl>Small PFS Bump in Synovial Sarcoma With Novel Drugѻýҕl> But questions raised over control arm and whether improvement represents a meaningful benefit Jun 05, 2021
<ѻýҕl>PD-1 Inhibitor Shows Benefit in Nasopharyngeal Cancerѻýҕl> Toripalimab plus first-line chemo improved survival in recurrent/metastatic disease Jun 03, 2021
<ѻýҕl>Survival Boost With First-Line Immunotherapy for Esophageal Cancerѻýҕl> Nivolumab plus ipilimumab or chemo offers new option for advanced, metastatic disease Jun 03, 2021
<ѻýҕl>First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancerѻýҕl> Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
<ѻýҕl>Radiation Speeds Up Biological Aging in Head and Neck Cancerѻýҕl> Epigenetic age acceleration linked with greater inflammation and fatigue Jun 01, 2021
<ѻýҕl>Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancerѻýҕl> No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
<ѻýҕl>Drug to Delay T1D Gets Tepid Endorsement by FDA Advisorsѻýҕl> Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
<ѻýҕl>Hospital at Home May Reduce Hospitalization, Costs for Cancer Patientsѻýҕl> Study demonstrated efficacy, cost-effectiveness of providing hospital-level services at home May 26, 2021
<ѻýҕl>Lymph Node Findings on PET: Cancer or COVID Vaccine?ѻýҕl> Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<ѻýҕl>Potassium Acid Blocker No Better Than PPI for Artificial Gastric Ulcersѻýҕl> Small Japanese trial found similar outcomes with both drugs May 25, 2021
<ѻýҕl>Op-Ed: A Door Opens to Transform Cancer Careѻýҕl> Incoming CMS Administrator Chiquita Brooks-LaSure brings hope to the cancer community May 25, 2021
<ѻýҕl>Test Can Predict Death Risk With Adrenal Tumorsѻýҕl> This can help guide need for surgical intervention, researcher says May 24, 2021
<ѻýҕl>RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancersѻýҕl> Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
<ѻýҕl>CHS Sues Thousands of Patients; Hospital Parking Fees Under Fire; Trump-Era Emailsѻýҕl> This past week in healthcare investigations May 19, 2021
<ѻýҕl>Impressive Results With Lenvatinib in Challenging Tumorsѻýҕl> Multitargeted TKI achieves strong ORR in advanced gastroenteropancreatic NETs May 10, 2021
<ѻýҕl>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosusѻýҕl> Mixed results from two small randomized clinical trials May 10, 2021
<ѻýҕl>Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer?ѻýҕl> Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
<ѻýҕl>What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?ѻýҕl> Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
<ѻýҕl>'It's a Straw-Man Argument': What We Heard This Weekѻýҕl> Quotable quotes from ѻýҕl's sources May 02, 2021
<ѻýҕl>FDA Panel Splits on Anti-PD-1 Monotherapy in HCCѻýҕl> All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
<ѻýҕl>What to Do With a Rare, Aggressive Bladder Cancerѻýҕl> Case authors lament scant information on treatments or outcomes Apr 26, 2021
<ѻýҕl>PD-1 Inhibitor Approved for dMMR Endometrial Cancerѻýҕl> Dostarlimab led to 42.3% response rate in recurrent/advanced disease Apr 22, 2021
<ѻýҕl>Surveillance Spurned for Small Papillary Thyroid Tumorsѻýҕl> Nearly all head and neck surgeons would opt for lobectomy or total thyroidectomy Apr 22, 2021
<ѻýҕl>Olympic Gold Medalist Nathan Adrian's Testicular Cancerѻýҕl> The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
<ѻýҕl>Another Player in Advanced Bladder Cancerѻýҕl> Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
<ѻýҕl>Another FGFR Inhibitor Active in Bile Duct Cancersѻýҕl> Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
<ѻýҕl>Practice-Changing Results in Metastatic Uveal Melanomaѻýҕl> Bispecific T cell-engaging tebentafusp reduces survival hazard by 50% Apr 10, 2021
<ѻýҕl>No Cancer Risk With Commonly Used Blood Pressure Medsѻýҕl> Largest analysis yet but definitive data remain elusive Apr 05, 2021
<ѻýҕl>Anti-PD-L1 Flops in Locally Advanced Head and Neck Cancerѻýҕl> No PFS benefit from adding avelumab to chemoradiation, hazard ratio favored placebo Apr 02, 2021
<ѻýҕl>A Win for Adjuvant Immunotherapy in Esophageal Cancerѻýҕl> And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
<ѻýҕl>Model: Give COVID-19 Vaccine to All Patients Before Surgeryѻýҕl> Prioritizing surgical patient population could avert more COVID deaths Mar 25, 2021
<ѻýҕl>Op-Ed: Blood Cancer Patients Need More COVID Vax Answersѻýҕl> Patients are left wondering, "will I be protected?" Mar 24, 2021